Mary Madison, RN, RAC-CT, CDPClinical Consultant – Briggs Healthcare The title of this blog is also the title of a just-released Kaiser Family Foundation (KFF) report.   I’m providing two (2) of the tables with corresponding data notes for this blog in hope that your interest will be tweaked and you read the entire report.  You…… Continue reading COVID-19 LTC Deaths and Cases Are at An All-Time Low, Though a Rise In LTC Cases in a Few States May Be Cause for Concern

Mary Madison, RN, RAC-CT, CDPClinical Consultant – Briggs Healthcare CMS has posted the latest nursing home data for week ending April 11, 2021. CDC has posted the latest data for vaccinations in LTC as of April 22, 2021 … 6am (ET). NHSN COVID-19 data as of April 19, 2021 … 5:30am (ET):

Mary Madison, RN, RAC-CT, CDPClinical Consultant – Briggs Healthcare Yesterday (April 20, 2021) I blogged on this FDA announcement.  Later in the day, CMS published a Special Edition – MLN Connects that provides this information: On April 16, the FDA revoked the Emergency Use Authorization (EUA) for bamlanivimab, when administered alone, due to a sustained increase…… Continue reading COVID-19 Update: FDA Revoked the EUA for Bamlanivimab When Administered Alone

Mary Madison, RN, RAC-CT, CDPClinical Consultant – Briggs Healthcare HHS Secretary Xavier Becerra renewed this PHE declaration on April 15, 2021: Note that this website provides links to additional resources for emergency and response information, including EUAs and Section 1135 Waivers. If you remember, HHS extended the PHE through the end of 2021 at a…… Continue reading Renewal of Determination That A Public Health Emergency Exists

Mary Madison, RN, RAC-CT, CDPClinical Consultant – Briggs Healthcare FDA Revoked Emergency Use Authorization for Monoclonal Antibody Bamlanivimab on Friday, April 16, 2021.  The U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults…… Continue reading Updated COVID-19 Information as of April 20, 2021

Mary Madison, RN, RAC-CT, CDPClinical Consultant – Briggs Healthcare If you weren’t able to attend this April 15, 2021 COCA Call, you view the recording (57 minutes, 26 seconds) here as well as obtain the 61-slide handout.  I encourage you to listen to the recording and review the slides.  This is important information.  Facility staff,…… Continue reading Johnson & Johnson/Janssen COVID-19 Vaccine and Cerebral Venous Sinus Thrombosis with Thrombocytopenia – Update for Clinicians on Early Detection and Treatment (COCA Call)

Mary Madison, RN, RAC-CT, CDPClinical Consultant – Briggs Healthcare CMS has posted the most recent county positivity rates – April 19, 2021.  My usual reminders: Archived dataInformation regarding testing regulations and guidelines 

Mary Madison, RN, RAC-CT, CDPClinical Consultant – Briggs Healthcare As COVID-19 vaccinations continue to be administered nationwide, OIG reminds vaccine providers and the public that this vaccine is being provided by the Federal Government and must be administered at no cost to recipients. Providers participating in the Centers for Disease Control and Prevention’s (CDC’s) COVID-19…… Continue reading COVID-19 Vaccination Program and Provider Compliance

Mary Madison, RN, RAC-CT, CDPClinical Consultant – Briggs Healthcare Wednesday April 21, 2021 at 4pm EST – Join the Centers for Medicare and Medicaid Services and The Centers for Disease Control and Prevention for a National Nursing Home Stakeholder Call.  *** Register in advance for this Zoom Call *** https://cms.zoomgov.com/webinar/register/WN_vXt-B2jtS4KfurWW_xaOuQ During the call, we’ll cover the…… Continue reading Upcoming CMS Nursing Home Stakeholder Call

Mary Madison, RN, RAC-CT, CDPClinical Consultant – Briggs Healthcare (On April 13, 2021), CDC and FDA recommended a pause in the use of the Johnson & Johnson (Janssen) COVID-19 vaccine pending an investigation into six reported U.S. cases of a rare and severe type of blood clot in individuals who received the vaccine. COVID-19 vaccine…… Continue reading Sharing an Update from the Centers for Disease Control and Prevention